USPTO serial 88804681
GENUV
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 20, 2020
- Examiner
- IM, JEAN H
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with GENUV?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $425
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kisuk Lee
Kisuk Lee HARNESS, DICKEY & PIERCE, PLC7700 BONHOMME AVE, SUITE 400ST. LOUIS, MO 63105UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | vaccines, adjuvants for use with vaccines, pharmaceutical preparations for veterinary use, for the treatment of cancer, autoimmune diseases, infectious diseases and neurodegenerative diseases; pharmaceutical preparations for the treatment of cancer, biological and chemical reagents for medical or veterinary purposes, nucleic acid sequences for medical and veterinary purposes, biotechnological preparations for medical purposes for the treatment of cancer, autoimmune diseases, infectious diseases and neurodegenerative diseases, biological preparations for medical purposes for the treatment of cancer, autoimmune diseases, infectious diseases and neurodegenerative diseases, living cells for medical purposes, pharmaceutical preparations for the treatment of infectious diseases and neurodegenerative diseases, pharmaceutical preparations for the treatment of autoimmune diseases, pharmaceutical preparations for the treatment of central nervous system diseases, diagnostic antibodies for use in disease testing, preparations, namely, cultures of microorganisms for medical or veterinary use, implants comprising living tissue | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 20, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 20, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 4, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 4, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 15, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 1, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 23, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 23, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 9, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 6, 2020 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Mar 4, 2020 | ALIE | ASSIGNED TO LIE | — |
| Feb 28, 2020 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 25, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 24, 2020 | NWAP | NEW APPLICATION ENTERED | — |